PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 163 filers reported holding PDL BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $271,000 | -10.0% | 86,296 | +6.5% | 0.00% | 0.0% |
| Q1 2019 | $301,000 | +15.8% | 81,023 | -9.5% | 0.00% | 0.0% |
| Q4 2018 | $260,000 | +25.0% | 89,576 | +13.1% | 0.00% | 0.0% |
| Q3 2018 | $208,000 | +30.0% | 79,222 | +16.1% | 0.00% | – |
| Q2 2018 | $160,000 | +17.6% | 68,212 | +47.3% | 0.00% | – |
| Q1 2018 | $136,000 | +277.8% | 46,313 | +247.9% | 0.00% | – |
| Q4 2017 | $36,000 | – | 13,311 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |